MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)
NCT02828917
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
de Novo or Restenosis Lesions
Interventions
DEVICE:
MedJ-01 Ridaforolimus Eluting Coronary Stent System
Sponsor
Medinol Ltd.